Carta Healthcare Takes Home Gold at the 2026 Stevie Awards
In a significant milestone for the healthcare technology sector, Carta Healthcare has been awarded the Gold medal for Technical Innovation of the Year in Digital Health at the prestigious 2026 Stevie Awards for Technology Excellence. This accolade marks the second consecutive year that Carta has been recognized in this esteemed program, a remarkable rise from their previous Silver award in 2025.
The Stevie Awards are internationally recognized as one of the leading business awards, celebrating excellence across various technology fields, including artificial intelligence and biotechnology. Kassina Healthcare's accolade stems from their nomination titled "Hybrid Intelligence for Trustworthy Clinical Data Abstraction," showcasing how they tackle one of the most persistent operational challenges in healthcare: the manual and often cumbersome process of clinical data abstraction.
Pioneering a New Approach with Hybrid Intelligence
Founded in 2017, Carta Healthcare emerged from a pressing need to streamline clinical data collection in environments like Stanford Children's Hospital, driven by frustrations with the manual process. The organization recognized that inefficiencies in data collection not only extended timelines but also incurred costs between $10 billion and $15 billion annually for U.S. health systems. Their innovative response, dubbed Hybrid Intelligence, integrates the clinical expertise of credentialed abstractors with advanced AI capabilities based on Anthropic's Claude technology.
As of now, Carta Healthcare proudly serves over 125 hospitals across the nation, fully supporting more than 70 registries. An impressive 100% customer retention rate since inception speaks volumes about the effectiveness of their model and the satisfaction of their clients. Their Hybrid Intelligence platform has enabled health organizations to reduce clinical data abstraction time by an astonishing 66%, resulting in cost savings of over 50% while maintaining an exceptional data accuracy rate of 98-99%, the highest standard in the industry for Inter-Rater Reliability.
Brent Dover, CEO of Carta Healthcare, emphasized the significance of their Hybrid Intelligence model, stating, "Good AI is not good enough for clinical data abstraction, where a single misread value can skew a quality measure. Achieving precision in registry questions, especially at scale, demands a combination of AI and clinical judgment, with each performing what they excel at." This award marks a continuation of their momentum, reflecting the transformative results achieved by their clientele.
Observing the Impact of Hybrid Intelligence
The recognition from the Stevie Awards serves as a testament to Carta Healthcare’s dedication to improving healthcare data management. By blending advanced AI technologies with clinical acumen, they are not just enhancing operational efficiencies but also aiming for better patient outcomes through improved data accuracy.
Moreover, Carta Healthcare has garnered numerous industry accolades along its journey, including the Merit Award for Best Use of AI in Healthcare, recognition in the CB Insights Digital Health 50, and the BIG Innovation Award. Their ongoing innovations signal a new era in healthcare data management strategies and methodologies, aiming to redefine the landscape for healthcare providers and systems.
As healthcare continues evolving in the digital age, the lessons learned and technologies developed by Carta Healthcare highlight the importance of integrating human expertise with sophisticated technology to tackle real-world challenges effectively. To learn more about the Stevie Awards and their significant contributions to the healthcare sector, one can explore the detailed awards program and its impact on the industry.
For additional information regarding Carta Healthcare’s hybrid approach to clinical data management and its vision for the future of healthcare, please visit
carta.healthcare.